These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3720)

  • 21. Biochemical studies in cases of childhood liver cirrhosis.
    Khalifa AA; Badrawy F; Shawky R; Farag RM; Tash FM
    J Egypt Soc Parasitol; 1983 Dec; 13(2):533-8. PubMed ID: 6141208
    [No Abstract]   [Full Text] [Related]  

  • 22. [Critical evaluation of the serum enzymatic diagnosis of liver diseases].
    Sposito M; Albertini Petroni V; Hassan G; Marinucci G; Valeri L
    Quad Sclavo Diagn; 1971 Dec; 7(4):1036-49. PubMed ID: 4144704
    [No Abstract]   [Full Text] [Related]  

  • 23. [Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
    Austerhoff A; Kindler U; Knop P; Knieriem HJ
    Dtsch Med Wochenschr; 1974 May; 99(22):1182 p. PubMed ID: 4835559
    [No Abstract]   [Full Text] [Related]  

  • 24. [The serum gamma-glutamyltranspeptidase level in clinical diagnosis (author's transl)].
    Mayr K
    Wien Klin Wochenschr; 1973 Feb; 85(6):83-7. PubMed ID: 4155171
    [No Abstract]   [Full Text] [Related]  

  • 25. [The diagnostic significance of immunoglobulin determination in chronic liver diseases. I. Differential diagnostic accuracy of immunoglobulin changes and enzyme activities (author's transl)].
    Ortmans H; Wildhirt E; Welcke U; Tücke M
    MMW Munch Med Wochenschr; 1975 Oct; 117(42):1681-8. PubMed ID: 241934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mallory bodies in liver biopsies from chronic alcoholics. A comparative morphological, biochemical, and clinical study of two groups of chronic alcoholics with and without Mallory bodies.
    Christoffersen P; Eghöje K; Juhl E
    Scand J Gastroenterol; 1973; 8(4):341-6. PubMed ID: 4729204
    [No Abstract]   [Full Text] [Related]  

  • 27. [Serochemical differential diagnosis of chronic liver diseases by means of discrimination analysis with special reference to the mesenchyma].
    van Husen N; Eberhardt G; Gerlach U; Intorp HW; Oberwittler W
    Z Gastroenterol; 1974 Jul; 12(5):327-34. PubMed ID: 4138663
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical correlations in alcoholic patients without manifest cirrhosis.
    Bordalo O; Batista A; Geraldes J; Neto F; Mascarenhas F; Leitao N; Noronha M; Lamy J; Silva PE
    Am J Gastroenterol; 1974 May; 61(5):371-8. PubMed ID: 4835934
    [No Abstract]   [Full Text] [Related]  

  • 29. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
    Spech HJ; Liehr H; Mitschke H
    Z Gastroenterol; 1983 Nov; 21(11):651-9. PubMed ID: 6659631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnostic significance of a high ASAT-ALAT (GOT-GPT) ratio in patients with very high serum aminotransferase levels.
    Wallerstedt S; Olsson R; Waldenström J
    Acta Med Scand; 1974 Mar; 195(3):227-9. PubMed ID: 4821290
    [No Abstract]   [Full Text] [Related]  

  • 31. [Serum glutamyl transpeptidase (GGTP) in chronic alcoholism].
    Adzharov D; Ivanov E
    Vutr Boles; 1974; 13(2):99-106. PubMed ID: 4154070
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the value of galactose tolerance test in the enzymatic determination of blood galactose level].
    Mehnert H; Haslbeck M; Förster H
    Dtsch Med Wochenschr; 1968 Oct; 93(40):1899-905. PubMed ID: 5679122
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical diagnosis of alcoholic fatty liver.
    Devenyi P; Rutherdale J; Sereny G; Olin JS
    Am J Gastroenterol; 1970 Dec; 54(6):597-602. PubMed ID: 5504217
    [No Abstract]   [Full Text] [Related]  

  • 34. [Value of determining gamma-glutamyltransferase, alkaline phosphatase and aspartate and alanine aminotransferase activities in the evaluation of liver damage in alcoholics].
    Laskus T; Szczutowska E; Babiuch L; Poplewska M; Mormul E
    Pol Tyg Lek; 1988 Apr; 43(14):438-40. PubMed ID: 2901075
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical studies of alcoholic hepatic diseases.
    Nakamura T; Nakamura S; Suzuki O; Aikawa T; Onodera A; Karoji N
    Tohoku J Exp Med; 1967 Oct; 93(2):179-89. PubMed ID: 5586574
    [No Abstract]   [Full Text] [Related]  

  • 36. [Elevation of liver enzymes in a patient with chronic hepatitis B during alpha-interferon treatment: what is it all about?].
    Tiesmeier J; Dienes HP; Schuppert F
    MMW Fortschr Med; 2009 Sep; 151(37):48-50. PubMed ID: 19827430
    [No Abstract]   [Full Text] [Related]  

  • 37. [Reference values for the determination of GOT, GPT, and alkaline phosphatase in serum with optimal standard methods (author's transl)].
    Thefeld W; Hoffmeister H; Busch EW; Koller PU; Vollmar J
    Dtsch Med Wochenschr; 1974 Feb; 99(8):343-4 passim. PubMed ID: 4150784
    [No Abstract]   [Full Text] [Related]  

  • 38. [Differential diagnostic significance of the so-called cholestasis-indicative serum enzymes].
    van Husen N; Eberhardt G; Gerlach U
    Med Welt; 1976 Jun; 27(24):1191-2. PubMed ID: 7725
    [No Abstract]   [Full Text] [Related]  

  • 39. The significance of Mallory bodies in the progression of fatty liver into cirrhosis.
    Christoffersen P; Juhl E
    Acta Pathol Microbiol Scand A; 1974 Jul; 82(4):483-6. PubMed ID: 4137298
    [No Abstract]   [Full Text] [Related]  

  • 40. [Frequency, diagnosis, and course of hepatotoxic side effects of Rifampicin (author's transl)].
    Deck KA; Gehrhardt A; Klein HO; Ludes H
    Med Klin; 1976 Oct; 71(43):1836-41. PubMed ID: 995024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.